Another report described legal action over unapproved copycat products
In preclinical models, they have demonstrated significant effects in reversing hepatic steatosis, inhibiting inflammation, and delaying fibrosis
And then they're kind of working towards getting that back over the first 3 to 6 months after treatment
doi: 10.1001/jamapsychiatry.2024.4789 l Clinical observation and some preliminary studies suggest the GLP-1 medication semaglutidebetter known by brand names like Ozempic, Mounjaro, and Wegovycan reduce cravings and help individuals with alcohol use disorder reduce or stop drinking
For patients who qualify, consider transitioning to an FDA-approved GLP-1 receptor agonist when supply, insurance coverage, and affordability permit
Reactivating dormant follicles Pelage Pharmaceuticals is pursuing a metabolic approach rooted in emerging insights into hair follicle stem cell (HFSC) biology